Subclinical Cushing syndrome (SCS) is a hypothalamic-pituitary-adrenal axis abnormality characterized by autonomous cortisol secretion in patients with no typical signs or symptoms of Cushing syndrome. SCS patients may have adverse metabolic and cardiovascular effects due to slight, but continuous glucocorticoid secretion. Glucocorticoids also affect behavior, mood, neural activity, and a number of specific biochemical processes in the central nervous system. Here, we report a case of SCS due to an adrenal incidentaloma in a hypertensive diabetic patient who presented with chronic fatigue and anxiety that disappeared after the removal of the adrenal adenoma.
slight, but chronic cortisol excess. 1, 2) SCS is prevalent in 79 people per 100,000, 3) and in 5% to 20% of adrenal incidentalomas. [4] [5] [6] [7] Improvements in abdominal imaging technologies have led to increased detection of adrenal incidentalomas and are thus expected to increase the frequency of diagnosing SCS. In this study, we report a case of SCS due to an incidental adrenal mass in a hypertensive diabetic patient who presented with anxiety and chronic fatigue without the typical symptoms of Cushing syndrome.
CASE REPORT
A 51-year-old woman visited the department of family medicine, Pusan National University Yangsan Hospital, Yangsan, Korea, complaining of a 2-year history of anxiety and fatigue.
She had previously visited a cardiologist and was diagnosed with early-stage diabetes with known hypertension, and prescribed
INTRODUCTION
Autonomous cortisol secretion in patients with no typical signs or symptoms of hypercortisolism is defined as "subclinical Cushing syndrome" (SCS). An increased frequency of hypertension, central obesity, impaired glucose tolerance or diabetes, hyperlipemia, and osteoporosis have been described in patients with SCS, possibly because these patients are exposed to a 
DISCUSSION
An adrenal "incidentaloma" is an adrenal mass that is discovered serendipitously during a radiologic examination performed for clinical conditions other than adrenal disease. 8) It is found in 6% of autopsies. 8, 9) The widespread use of abdominal ultrasonography (US), CT, and magnetic resonance imaging has increased the detection of adrenal incidentaloma (range, 0.4% to 6% of all US and CT). [10] [11] [12] Most adrenal incidentalomas are non- (range, 3% to 10%), aldosterone (1%), and the sex hormone (range, 0% to 11%). 13, 14) Recent reports suggest that up to 20%
of patients with an adrenal incidentaloma have some form of subclinical hormonal dysfunction and may represent a population at higher risk for metabolic disorders and cardiovascular disease.
11)
Adequate evaluation and treatment are necessary to identify functioning or malignant tumors, which are generally resected.
SCS is a hypothalamic-pituitary-adrenal (HPA) axis abnormality defined as autonomous cortisol secretion in patients with no typical signs or symptoms of hypercortisolism such as moon face, buffalo hump, or purple striae. Although whether subclinical hypercortisolism progresses to overt Cushing syndrome has not yet been established, the progression toward overt Cushing syndrome seems to occur only rarely. 6, 15, 16) Therefore, SCS is a more appropriate term than preclinical
Cushing syndrome. SCS patients may have adverse metabolic and cardiovascular effects including hypertension, obesity, diabetes mellitus, and osteoporosis, due to the continuous glucocorticoid secretion. 2, [17] [18] [19] [20] Glucocorticoids also affect behavior, mood, neural activity, and a number of specific biochemical processes in the central nervous system. 17) The presence of depressive symptoms can be an early manifestation of HPA axis abnormalities and Cushing syndrome. 21) Normalization of cortisol levels generally improves depressive as well as other disabling psychological symptoms. [21] [22] [23] The progression towards overt clinical Cushing syndrome is rare and not obvious. 8, [24] [25] [26] 
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